Debreceni L, Hartmann G
Acta Physiol Hung. 1983;61(1-2):99-103.
Pituitary-adrenocortical function and the changes of hypothalamic catecholamine content were studied following alpha-methyl-dopa treatment in rats. After three-day administration of alpha-methyl-dopa the plasma corticosterone concentration increased significantly and at the same time ether stress failed to elicit a pituitary-adrenocortical response. Moreover, the alpha-methyl-dopa pretreatment prevented the facilitatory effect of physostigmine on pituitary-adrenocortical activation. As the result of alpha-methyl-dopa treatment the norepinephrine content decreased significantly and the amount of compounds measured as dopamine (dopamine, alpha-methyl-dopamine and alpha-methyl-dopa) increased in the hypothalamus. It is concluded that the impaired metabolism of catecholamines may inhibit the pituitary-adrenocortical activation to stimulation, and that not only norepinephrine and dopamine, but other phenylalanine derivatives and alpha-methyl-dopa may also influence the responsiveness of pituitary-adrenocortical function.
研究了大鼠α-甲基多巴治疗后垂体-肾上腺皮质功能及下丘脑儿茶酚胺含量的变化。给予α-甲基多巴三天后,血浆皮质酮浓度显著升高,同时乙醚应激未能引发垂体-肾上腺皮质反应。此外,α-甲基多巴预处理可阻止毒扁豆碱对垂体-肾上腺皮质激活的促进作用。α-甲基多巴治疗的结果是,下丘脑去甲肾上腺素含量显著降低,以多巴胺(多巴胺、α-甲基多巴胺和α-甲基多巴)测定的化合物量增加。得出的结论是,儿茶酚胺代谢受损可能抑制垂体-肾上腺皮质对刺激的激活,并且不仅去甲肾上腺素和多巴胺,其他苯丙氨酸衍生物和α-甲基多巴也可能影响垂体-肾上腺皮质功能的反应性。